Screening for Diabetic Retinopathy and Diabetic Macular Edema in the United Kingdom

被引:56
|
作者
Peto, Tunde [1 ,2 ,3 ]
Tadros, Christine [1 ,2 ,3 ]
机构
[1] Moorfields Eye Hosp NHS Fdn Trust, Reading Ctr, Dept Res & Dev, London EC1V 2PD, England
[2] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London EC1V 2PD, England
[3] UCL Inst Ophthalmol, London, England
关键词
Diabetic retinopathy; Diabetic macular edema; Screening; Prevention; Visual loss; QUALITY-OF-LIFE; COST-EFFECTIVENESS; RISK-FACTORS; PHOTOCOAGULATION; RANIBIZUMAB; ASSOCIATION; PROGRESSION; MELLITUS; TRIAL; EYE;
D O I
10.1007/s11892-012-0285-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite advances in screening for and treatment of diabetes, diabetic retinopathy and maculopathy are still major causes of visual loss around the world. Systematic screening programs for diabetic eye disease have been developed in many countries. The main aim of these services is to reduce diabetes-related blindness and ease the burden of illness on the patients and their families. In the United Kingdom (UK), the NHS Diabetic Eye Screening Program offers annual digital fundus photography for all patients with diabetes over the age of 12 years regardless of their socio-economic status or ethnicity. In 2010-2011 a nationwide uptake of 79% was achieved. If disease is identified, referral to a specialized eye unit for further assessment and treatment are organized to take place within a pre-specified time frame. Internal and external quality assurance ensures efficacy and safety. This paper aims to summarize the current situation of diabetic retinopathy screening in the UK and outlines the challenges ahead.
引用
收藏
页码:338 / 345
页数:8
相关论文
共 50 条
  • [1] Screening for Diabetic Retinopathy and Diabetic Macular Edema in the United Kingdom
    Tunde Peto
    Christine Tadros
    [J]. Current Diabetes Reports, 2012, 12 : 338 - 345
  • [2] Diabetic retinopathy and diabetic macular edema - Pathophysiology, screening, and novel therapies
    Ciulla, TA
    Amador, AG
    Zinman, B
    [J]. DIABETES CARE, 2003, 26 (09) : 2653 - 2664
  • [3] Classification of diabetic retinopathy and diabetic macular edema
    Wu, Lihteh
    Fernandez-Loaiza, Priscilla
    Sauma, Johanna
    Hernandez-Bogantes, Erick
    Masis, Marisse
    [J]. WORLD JOURNAL OF DIABETES, 2013, 4 (06) : 290 - 294
  • [4] Imaging of Diabetic Retinopathy and Diabetic Macular Edema
    Danis, Ronald P.
    Hubbard, Larry D.
    [J]. CURRENT DIABETES REPORTS, 2011, 11 (04) : 236 - 243
  • [5] Imaging of Diabetic Retinopathy and Diabetic Macular Edema
    Ronald P. Danis
    Larry D. Hubbard
    [J]. Current Diabetes Reports, 2011, 11 : 236 - 243
  • [6] Imaging and Biomarkers in Diabetic Macular Edema and Diabetic Retinopathy
    Changyow C. Kwan
    Amani A. Fawzi
    [J]. Current Diabetes Reports, 2019, 19
  • [7] Multifocal Electroretinography in Diabetic Retinopathy and Diabetic Macular Edema
    Bearse, Marcus A., Jr.
    Ozawa, Glen Y.
    [J]. CURRENT DIABETES REPORTS, 2015, 15 (09)
  • [8] Pharmacologic therapies for diabetic retinopathy and diabetic macular edema
    Rechtman, Ehud
    Harris, Alon
    Garzozi, Hanna J.
    Ciulla, Thomas A.
    [J]. CLINICAL OPHTHALMOLOGY, 2007, 1 (04): : 383 - 391
  • [9] Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
    Jie Ding
    Tien Yin Wong
    [J]. Current Diabetes Reports, 2012, 12 : 346 - 354
  • [10] Multifocal Electroretinography in Diabetic Retinopathy and Diabetic Macular Edema
    Marcus A. Bearse
    Glen Y. Ozawa
    [J]. Current Diabetes Reports, 2014, 14